THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deck

First Page		Document Content
Date: 2013-05-21 21:35:48 Pyridines Benzamides Bristol-Myers Squibb Organofluorides Dipeptidyl peptidase-4 inhibitor Tofacitinib Pfizer GlaxoSmithKline Axitinib Chemistry Organic chemistry Carbamates		THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deck Add to Reading List Source URL: media.mmm-online.com Download Document from Source Website File Size: 133,15 KB Share Document on Facebook

	Cardiovascular Pipeline April 6, 2010 DocID: 1amKm - View Document
	440 PRIMARY CARE DIABETOLOGY Initiating oral anti diabetic drug: alternatives to metformin Sanjay Kalra,1 Yashdeep Gupta2 DocID: 118aS - View Document
	DIABETES MANAGEMENT IN PRACTICE Nneka Agbasi Diabetes Specialist Nurse - ECS DocID: 10wjp - View Document
	THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deck DocID: RPcB - View Document
	THE PIPELINE REPORT[removed]Latestage Standouts Spotlighting 196 agents, with profiles on 15 advances vying to be better, safer or cheaper than DocID: QHDk - View Document